摘要：目的 探讨米非司酮用于高危中期妊娠引产的临床效果及安全性。方法 通过观察我院2002年1月至2006年12月因有高危因素不宜继续妊娠而来我院要求引产的妇女，分为米非司酮联合利凡诺羊膜腔内注射组为观察组，单用利凡诺羊膜腔内注射为对照组，通过观察其宫缩发动时间，宫缩强度，产时并发症发生情况，胎儿胎盘排出时间，产时产后出血量等进行回顾性分析比较。结果 米非司酮联合利凡诺羊膜腔内注射用于高危中期妊娠引产的安全度，宫缩发动时间，胎儿胎盘娩出时间，产时产后出血量等情况明显优于单用利凡诺引产组。结论 在无服用米非司酮禁忌情况下，米非同酮用于高危中期妊娠引产在缩短患者腹痛时间(缩短替伏期)，减轻患者痛苦，降低引产风险方面有其明显的优越性。

    关键词 米非司酮 利凡诺 高危中期妊娠 引产

    Clinical Observation of 48 Cases Patients During the induction of Labor in Midpregnancy with High Risk Treated by Mifepristone.Liang Min.TongNan county people's hospital, Tongnan 402660, Chongqing,China.

    【Abstract】Objective To explore the clinical effectiveness and safety of using Mifepristone in the induction of labor in midpregnancy with high risk.Methods To observe the women who are not suitable for pregnancy because of high risk factor and requested to termination of pregnancy from 2002 January to 2006 December . The patients in the observation group were treated by combination of Mifepristone and Rivanol intra-amniotic injection,while the control group were treated only by Rivanol.We conducted a retrospective analysis and comparison in view of uterine contraction time , intensity of uterine contraction ,complication, efflux time of foetal placenta ,and the blood volum in labor course and postpostpartum hemorrhage.Results The effect of the observation group that using Mifepristone combined with Rivanol in aboration was significantly superior to the control group.Conclusion In the case of no contraindication of using Mifepristone, Mifepristone use for the induced abortion in high-risk exhibits obvious advantages in many aspects such as shorten eclipse period, sofen patient's painful , reduce the risk et al. ...... 如果您在使用手机等流览时无法查看或下载全文，可能是被搜索引擎失真“转码”，请点击屏幕最下方的“电脑版”或“原网页”访问。


限于服务器压力，网站部分信息只供爱心会员或有一定积分的注册会员流览。
此信息需要 2 积分（免费注册登录后每天可以领取10个积分）。

用户名：
密 码：
	忘了密码

如果您还不是100md.com会员，欢迎 免费注册，
如果您想获得积分，点击这里 查看积分规则。
如果您想订购杂志，请直接与《中国医药学刊》编辑部联系。     信息仅供参考，不构成任何之建议、推荐或指引。文章版权属于原著作权人，若您认为此文不宜被收录供大家免费阅读，请邮件或电话通知我们，我们收到通知后，会立即将您的作品从本网站删除。

微信文章  关注百拇  评论几句  搜索更多